Cargando…
Effectiveness of cetuximab as preemptive postsurgical therapy for oral squamous cell carcinoma patients with major risk: a single‐center retrospective cohort study
A retrospective cohort study was performed to investigate the effectiveness of preemptive postsurgical therapy with cetuximab for patients with a major risk of recurrence or metastasis after clinical complete resection of primary oral squamous cell carcinoma (OSCC). The study period was from 2007 to...
Autores principales: | Fukumoto, Chonji, Sawatani, Yuta, Shiraishi, Ryo, Zama, Manabu, Shimura, Michiko, Hasegawa, Tomonori, Komiyama, Yuske, Fujita, Atsushi, Wakui, Takahiro, Kawamata, Hitoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068704/ https://www.ncbi.nlm.nih.gov/pubmed/33449240 http://dx.doi.org/10.1007/s10637-021-01062-0 |
Ejemplares similares
-
Paclitaxel Potentiates the Anticancer Effect of Cetuximab by Enhancing Antibody-Dependent Cellular Cytotoxicity on Oral Squamous Cell Carcinoma Cells In Vitro
por: Sawatani, Yuta, et al.
Publicado: (2020) -
Surveillance for Patients with Oral Squamous Cell Carcinoma after Complete Surgical Resection as Primary Treatment: A Single-Center Retrospective Cohort Study
por: Fukumoto, Chonji, et al.
Publicado: (2021) -
Primary syphilis with a tongue ulcer mimicking tongue cancer: a case
report
por: Fukumoto, Chonji, et al.
Publicado: (2023) -
Identification of Binding Proteins for TSC22D1 Family Proteins Using Mass Spectrometry
por: Kamimura, Ryouta, et al.
Publicado: (2021) -
The mutational spectrum in whole exon of p53 in oral squamous cell carcinoma and its clinical implications
por: Hyodo, Toshiki, et al.
Publicado: (2022)